// App-Quantinova.ai

: Targeted Lung Denervation improves COPD symptoms and health related quality of life at 6-months

Researchers

Presenter

  • Dirk-Jan Slebos

Principal Investigators

  • Arschang Valipour

  • Pallav L Shah

  • Christophe Pison

  • GaTan Deslee

Medical Centers

  • Pulmonary Diseases AA11, University Medical Center Groningen, Groningen, Netherlands.

  • Ludwig-Boltzmann-Institute for COPD and Respiratory Epidemiology, Otto-Wagner-Spital, Austria,

  • NIHR Respiratory Biomedical Research Unit, Royal Brompton and Harefield NHS Foundation Trust and Imperial College, Harefield, United Kingdom

  • CHU de Grenoble Clinique Universitaire de Pneumologie, Université Grenoble Alpes, Grenoble, France

  • Department of Pulmonary Medicine, INSERM UMRS 903, CHU of Reims, Reims, France

Locations

  • Netherlands

  • Austria

  • United Kingdom

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Chronic obstructive pulmonary disease

Biomarkers

  • Bone Morphogenetic Protein 1

  • Catalase

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Prospective

Phase

  • NA

Study Id's

  • NCT02058459

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved